Abstract
Background Bluetooth-based exposure notification apps can supplement manual contact tracing to reduce SARS-CoV-2 transmission. Their speed, scalability, and privacy preservation are generally acknowledged, but less exploited are smartphones’ accurate measurement of duration, and ability to automatically calculate risk from multiple inputs.
Methods We model uncertainty in the shape of an exhaled virus-containing plume, inhalation parameters, and distance as a function of Bluetooth attenuation. We assume relative rates of viral shedding depend on the timing of exposure relative to symptom onset. We calibrate an exponential dose-response curve on the basis of the infection probabilities of household contacts. The conditional probability of current or future infectiousness, conditioned on how long post-exposure an exposed individual has been free of symptoms, decreases during quarantine, with shape determined by the distribution of incubation periods, proportion of asymptomatic cases, and distribution of asymptomatic shedding durations. It can be adjusted for negative test results using Bayes Theorem.
Findings As an example of our calculations, fifteen minutes of close contact with a high-shedding individual, given a 15% asymptomatic infection rate and no testing, would require 5- and 14-day quarantine for their risk of current or future infectiousness to fall below 0.84% and 0.14% risk, respectively.
Interpretation The Covid-Watch app is currently programmed either to use a threshold on initial infection risk to determine 14-day quarantine onset, or on the conditional probability of current and future infectiousness conditions to determine both quarantine and duration. Either threshold can be set by public health authorities.
Funding University of Arizona
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding was provided by the University of Arizona.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The manuscript describes a new methodology, and no human subjects research is included in its scope.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The manuscript describes a method and does not include new data. The code is available at the github link provided in the text.